4//SEC Filing
FATE THERAPEUTICS INC 4
Accession 0001209191-16-121180
$FATECIK 0001434316operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 12:19 PM ET
Size
7.8 KB
Accession
0001209191-16-121180
Insider Transaction Report
Form 4
Storgard Chris
Chief Medical Officer
Transactions
- Award
Common Stock
2016-05-16+9,090→ 9,090 total - Award
Stock option (right to buy)
2016-05-16+200,000→ 200,000 totalExercise: $1.54Exp: 2026-05-15→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]Represents shares being issued pursuant to the Company's 2013 Stock Option and Incentive Plan as a portion of a signing bonus in connection with Dr. Storgard's agreement to enter into employment with the Company.
- [F2]This stock option is an inducement grant made under the Company's Inducement Equity Incentive Plan (the "Inducement Plan") pursuant to NASDAQ Stock Market Rule 5635(c)(4).
- [F3]Pursuant to the Inducement Plan, Dr. Storgard was granted an option to buy 200,000 shares of Common Stock. Twenty five percent of the shares subject to this option shall vest and become exercisable on May 16, 2017 and 1/48th of the shares shall vest and become exercisable monthly thereafter, so that one hundred percent of the shares shall be vested and exercisable on May 16, 2020.
- [F4]Not applicable.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeoperating
Related Parties
1- filerCIK 0001434316
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 12:19 PM ET
- Size
- 7.8 KB